[Ventricular tachycardia: the role of adrenergic stimulation in the prognosis of fatal arrhythmia].
A new method for appraising the individual efficacy of an antiarrhythmic agent is described. It is based on paired administration of isoprenaline and testing antiarrhythmics for maximum activity. The possibility of provoking ventricular tachycardia by isoprenaline made it possible to identify a contingent of patients with "catecholamine-sensitive" or "variable" tachycardia. The prognosis of "catecholamine-sensitive" ventricular tachycardia proved to be the worst in groups of patients with ischemic heart disease attended by postinfarction cardiosclerosis and in patients with arrhythmogenic dysplasia of the right ventricle.